Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Eur J Pharmacol ; 721(1-3): 12-20, 2013 Dec 05.
Article En | MEDLINE | ID: mdl-24120659

Voltage-dependent type 7 K(+) (KV7 or KCNQ) channels modulate the excitability of neurons and muscle cells. The aims of the present study were to investigate the motor effects of KV7 channel modulators and the expression of KV7 channels in the human taenia coli. The effects of KV7 channel modulators on the muscle tone of human taenia coli strips were investigated under nonadrenergic non-nitrergic conditions by organ bath studies. Gene expression and tissue localisation of channels were studied by real-time PCR and immunohistochemistry, respectively. Under basal conditions, the KV7 channel blocker XE-991 induced concentration-dependent contractions, with mean EC50 and Emax of 18.7 µM and 30.5% respectively of the maximal bethanechol-induced contraction, respectively. The KV7 channel activators retigabine and flupirtine concentration-dependently relaxed the taenia coli, with mean EC50s of 19.2 µM and 29.9 µM, respectively. Retigabine also relaxed bethanechol-precontracted strips, with maximal relaxations of 79.2% of the bethanecol-induced precontraction. The motor effects induced by the KV7 channel modulators were not affected by tetrodotoxin or ω-conotoxin GVIA. XE-991 greatly reduced retigabine- and flupirtine-induced relaxations. Transcripts encoded by all KCNQ genes were detected in the taenia coli, with KCNQ4 showing the highest expression levels. KV7.4 channels were clearly visualised by immunohistochemistry in colonic epithelium, circular muscle layer and taenia coli. KV7 channels appear to contribute to the resting muscle tone of the human taenia coli. In addition, KV7 channel activators significantly relax the taenia coli. Thus, they could be useful therapeutic relaxant agents for colonic motor disorders.


Colon/physiology , Gastrointestinal Motility , Gene Expression Regulation , KCNQ Potassium Channels/genetics , KCNQ Potassium Channels/metabolism , Aged , Aged, 80 and over , Aminopyridines/pharmacology , Anthracenes/pharmacology , Carbamates/pharmacology , Colon/metabolism , Gastrointestinal Motility/drug effects , Gene Expression Regulation/drug effects , Humans , In Vitro Techniques , Middle Aged , Phenylenediamines/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism
2.
Neurochem Int ; 57(8): 893-8, 2010 Dec.
Article En | MEDLINE | ID: mdl-20933034

Progranulin (PGRN) is a widely expressed multifunctional protein, involved in regulation of cell growth and cell cycle progression with a possible involvement in neurodegeneration. We looked for PGRN regulation in three different human neuroblastoma cell lines, following exposure to two different stimuli commonly associated to neurodegeneration: hypoxia and oxidative stress. For gene and protein expression analysis we carried out a quantitative RT-PCR and western blotting analysis. We show that PGRN is strongly up-regulated by hypoxia, through the mitogen-actived protein kinase (MAPK)/extracellular signal-regulated kinase (MEK) signaling cascade. PGRN is not up-regulated by H(2)O(2)-induced oxidative stress. These results suggest that PGRN in the brain could exert a protective role against hypoxic stress, one of principal risk factors involved in frontotemporal dementia pathogenesis.


Cytoprotection , Hypoxia, Brain/metabolism , Hypoxia, Brain/pathology , Intercellular Signaling Peptides and Proteins/biosynthesis , Neuroblastoma/metabolism , Neuroblastoma/pathology , Oxidative Stress/physiology , Up-Regulation , Cell Line, Tumor , Cytoprotection/genetics , Frontotemporal Dementia/etiology , Frontotemporal Dementia/pathology , Frontotemporal Dementia/prevention & control , Humans , Hypoxia, Brain/prevention & control , Intercellular Signaling Peptides and Proteins/genetics , Progranulins , RNA, Messenger/biosynthesis , Risk Factors , Up-Regulation/genetics
...